• Home
  • About GPCRCentral

GPCR News

Entries RSS | Comments RSS
  • Tags

    5-HT1A 5-HT2 5-HT2A 5-HT3 5-HT4 5-ht6 5HT1A 5HT1D 5HT2 5HT2A 5HT3 5HT4 5ht6 agonist Angiotensin II AT1 antagonist Astrazeneca Beta 2 adrenoceptor Cannabinoid CB1 Daiichi-Sankyo Dopamine Dopamine D2 Fentanyl ghrelin GlaxoSmithkline GLP-1 gpcr GSK Histamine H1 Licensing Lilly Merck Muscarinic Opioid Opioid mu phase I phase II phase III Preclinical regulatory Research Sanofi-Aventis TRPV1 Vanilloid
  •  

    September 2008
    M T W T F S S
    « Aug   Oct »
    1234567
    891011121314
    15161718192021
    22232425262728
    2930  

Wyeth publishes series of Neurotensin NTS1 Receptor Partial Agonists

Posted on September 29, 2008 by crimsoncanary

Wyeth have published a series of Neurotensin NTS1 Receptor Partial Agonists

Filed under: Uncategorized | Tagged: agonist, Neurotensin, NTS1, Preclinical, Research, Wyeth

« Watsons solidosin effective in BPH Neurocrine Biosciences publish series of adenosine A2A antagonists »

Leave a Reply

Click here to cancel reply.

  • Calendar

    • September 2008
      M T W T F S S
      « Aug   Oct »
      1234567
      891011121314
      15161718192021
      22232425262728
      2930  
  • Blogroll

    • CrimsonCanary.com
    • GPCRCentral.com
    • IonChannelCentral.com
    • Kinasecentral.com
    • Pharma Company Pipelines

Blog at WordPress.com. Theme: Digg 3 Column by WP Designer